Is MEDP or PODD cheaper?

On trailing earnings, MEDP is cheaper: MEDP trades at a 33.78 P/E and PODD at 38.92.

Which has grown faster, MEDP or PODD?

Over the past five years, PODD grew revenue faster — MEDP at a 22.91% CAGR versus PODD at 24.79%.

Is MEDP or PODD more profitable?

MEDP runs the higher net margin — MEDP at 17.19% versus PODD at 10.44%.

Which has been the better investment, MEDP or PODD?

Over the past 5-year, MEDP delivered the higher annualized total return — MEDP at 23.54% versus PODD at 17.13%. Past performance doesn't predict future results.

Medpace Holdings, Inc. (MEDP) vs Insulet Corp. (PODD)

PODD leads on 9 of 16 compared metrics, though MEDP is the cheaper stock.

A side-by-side comparison of Medpace Holdings, Inc. and Insulet Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 20, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

MEDP

Medpace Holdings, Inc.

$15.08B

$527.93HealthcareDelayed quote: Jul 20, 2026, 4:00 PM EDT

PODD

Insulet Corp.

$11.59B

$167.37HealthcareDelayed quote: Jul 20, 2026, 4:00 PM EDT

Total return — MEDP vs PODD

growth of $100 · dividends reinvested · last 10y

MEDP +1800.7%PODD +284.6%MEDP compounded faster

MEDP PODD

MEDP vs PODD: by the numbers

•MEDP is the larger company ($15.08B vs $11.59B market cap).
•MEDP trades at the lower earnings multiple (33.78 vs 38.92 P/E).
•MEDP converts more revenue to profit (17.19% vs 10.44% net margin).
•PODD grew revenue faster over the past five years (24.79% vs 22.91% CAGR).

Which is better, MEDP or PODD?

Metric tally: MEDP 7 · PODD 9

It depends on what you're optimizing for:

ValueMEDP(lower P/E)

GrowthPODD(faster 5Y revenue CAGR)

QualityMEDP(higher ROIC)

Metrics side by side

Valuation

Metric	MEDP	PODD
P/E ratio	33.78●	38.92
Forward P/E	31.69	25.84●
P/S ratio	5.81	4.05●
P/B ratio	26.03	9.02●
PEG ratio	1.82	0.39●
EV / EBITDA	25.45	20.08●
FCF yield	4.74%●	3.51%

Profitability

Metric	MEDP	PODD
Gross margin	29.07%	71.01%●
Operating margin	21.02%●	17.48%
Net margin	17.19%●	10.44%
ROE	76.95%●	23.25%
ROIC	67.94%●	13.62%

Growth (annualized)

Metric	MEDP	PODD
Revenue CAGR (5Y)	22.91%	24.79%●
EPS CAGR (5Y)	30.90%	99.91%●
FCF CAGR (5Y)	25.76%	79.41%●
Total return CAGR (5Y)	23.54%●	-9.32%

Frequently asked

Which is better, MEDP or PODD?: It depends on your goal. value: MEDP (lower P/E); growth: PODD (faster 5Y revenue CAGR); quality: MEDP (higher ROIC). Across all compared metrics, PODD leads 9 to 7.
Is MEDP or PODD cheaper?: On trailing earnings, MEDP is cheaper: MEDP trades at a 33.78 P/E and PODD at 38.92.
Which has grown faster, MEDP or PODD?: Over the past five years, PODD grew revenue faster — MEDP at a 22.91% CAGR versus PODD at 24.79%.
Is MEDP or PODD more profitable?: MEDP runs the higher net margin — MEDP at 17.19% versus PODD at 10.44%.
Which has been the better investment, MEDP or PODD?: Over the past 5-year, MEDP delivered the higher annualized total return — MEDP at 23.54% versus PODD at 17.13%. Past performance doesn't predict future results.

Go deeper

Full MEDP analysis Full PODD analysis Interactive comparison tool

Dig into the metrics

Medpace P/E ratio Insulet P/E ratio Medpace dividend yield Insulet dividend yield Medpace ROE Insulet ROE Medpace operating margin Insulet operating margin Medpace revenue growth Insulet revenue growth Medpace free cash flow Insulet free cash flow

Medpace & Insulet appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 20, 2026.